Additionally, an increasing number of researchers have reported that inhibition of the NLRP3 pathway can ameliorate epileptic seizure episodes and cognitive dysfunction [28–30]; therefore, the NLRP3 pathway could be considered a potential treatment target for epilepsy [31–33]. The gene discussed is NLRP3; the disease is epilepsy.